| Line Item | Jul 3, 2026 | Apr 3, 2026 | Jun 30, 2025 | Mar 31, 2025 |
|---|---|---|---|---|
| Revenue | ||||
| Cost of goods sold | ||||
| Gross profit | ||||
| % of revenue | 25.0% | 21.2% | ||
| Operating expenses: | ||||
| General and administrative | ||||
| Research and development | ||||
| Sales and marketing | ||||
| Total operating expenses | ||||
| % of revenue | 36.5% | 17.8% | ||
| Operating (loss) income | ||||
| % of revenue | -11.5% | 3.3% | ||
| Interest expense | — | |||
| Change in fair value of derivative asset | ||||
| (Gain) loss on remeasurement of the fair value of marketable securities | — | |||
| Other (income) expense, net | ||||
| Total other expense (income), net | ||||
| (Loss) income from continuing operations before taxes | ||||
| Income tax (benefit) provision | ||||
| (Loss) income from continuing operations | ||||
| Loss from discontinued operations | — | |||
| Net (loss) income | ||||
| % of revenue | -6.8% | -0.6% | ||
| Net (loss) income per share: | ||||
| Basic (in dollars per share) | — | |||
| Diluted (in dollars per share) |